The Protective Effect of Aged Garlic Extract on Nonsteroidal Anti-Inflammatory Drug-Induced Gastric Inflammations in Male Albino Rats

Badr, Gehan Moustafa; AL-Mulhim, Jawaher Abdulaziz

doi:https://doi.org/10.1155/2014/759642

Evidence-Based Complementary and Alternative Medicine

On this page

Abstract Introduction Methods Results Discussion Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2014 | Article ID 759642 | https://doi.org/10.1155/2014/759642

The Protective Effect of Aged Garlic Extract on Nonsteroidal Anti-Inflammatory Drug-Induced Gastric Inflammations in Male Albino Rats

Gehan Moustafa Badr^1,2and Jawaher Abdulaziz AL-Mulhim¹

Academic Editor: Juliano Ferreira

Received23 Feb 2014

Accepted03 Apr 2014

Published30 Apr 2014

Abstract

Natural products have long gained wide acceptance among the public and scientific community in the gastrointestinal ulcerative field. The present study explore the potential effects of aged garlic extract (AGE) on indomethacin-(IN-) induced gastric inflammation in male rats. Animals were divided into six groups () control group, IN-induced gastric inflammation group via oral single dose (30 mg/kg to fasted rats) two AGE orally administered groups (100 and 200 mg/kg for 30 consecutive days) two AGE orally administered groups to rats pretreated with IN at the same aforementioned doses. The results declared the more potent effect of the higher AGE dose (200 mg/kg) as compared to that of the 100 mg/kg dose in the gastroprotective effects reflected by significant gastric mucosal healing of damage and reduction in the total microbial induced due to indomethacin administration. In addition to the significant effect to normalize the significant increase in malondialdehyde (MDA), myeloperoxidase (MPO), tumor necrosis factor-α (TNF-α) values, and the significant decrease in the total glutathione (tGSH), superoxide dismutase (SOD), and catalase (CAT) values induced by indomethacin. The results support AGE antioxidant, anti-inflammatory, and antimicrobial potency reflected by the healing of the gastric tissue damage induced by indomethacin.

1. Introduction

The side effects of the anti-inflammatory drugs are one of the major problems in developing medicine today. Therefore, the concept of nutraceuticals evolved. Nutraceuticals are medicinal foods that have a role in maintaining wellbeing, enhancing health, modulating immunity, and thereby preventing as well as treating specific diseases [1]. Plants of the genus Allium known for their production of steroid, saponins, and organosulfur compounds, such as alliin, ajoene, are representative chemicals. Recently, fresh garlic found to have some interesting biological and pharmacological activities including antifungal and antibacterial effects [2, 3]. Aqueous garlic extract exerts antioxidant action by scavenging reactive oxygen species enhancing cellular antioxidant enzymes superoxide dismutase, catalase, and glutathione peroxidase [4]. Garlic represents an important source of antioxidant phytochemicals such as diallyl sulfide, S-allylmercaptocysteine, and ajoene, which is the optimal assurance for neutralizing free radical-mediated inflammation. It possesses hepatoprotective, neuroprotective, genoprotective, immunoprotective, and antioxidative activities [5–9].

Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used in the treatment of fever, pain, and inflammation. However, these drugs have some side effects, especially on the gastrointestinal tract such as gastric mucosal erosions, ulcerations, bleeding, and perforations. Many studies suggested that the mechanisms for the gastric damage caused by NSAIDs are inhibition of prostaglandin synthesis and inhibition of epithelial cell proliferation in the ulcer margin [10–12]. They stimulate HCl secretion and cause weakness of mucous gel layer, which act as barrier by decreasing mucin production and increasing the secretion of bicarbonate from gastric and duodenal mucosa [13]. Indomethacin (IN) is a nonsteroidal anti-inflammatory drug commonly used to reduce fever, pain, stiffness, and swelling. It works by inhibiting the production of prostaglandins, which normally protect the gastrointestinal mucosa from damage by maintaining blood flow and increasing mucosal secretion of mucous and bicarbonate [14]. Indomethacin has been shown to produce sever gastric damage in rats than did others and has become the preferred drug for inducing ulcer models [11, 12, 15]. The increased levels of reactive oxygen species (ROS) reported in the mechanism of both stress and IN-induced gastric damage [16]. The important roles of oxygen reactive species (ROS) which cause lipid peroxidation (LPO) have been known to play a critical role in the development of pathogenesis in acute gastric damage induced by stress, ethanol, and NSAIDs [17, 18].

Therefore, the present study was designed to explore the potential anti-inflammatory effects of AGE on an IN-induced gastric inflammation in male albino rats and to evaluate its effects on antioxidant parameters in rat stomach tissue and the level of TNF-α, a cytokine, plays an important role in inflammation.

2. Material and Methods

Experimental Animals. The present study was carried on (48) adult male albino rats (Rattus norvegicus), weighing ( g). Animals were housed in environmentally controlled conditions (temperature of 22 ± 2°C) with a 12 h light/dark cycle and had free access to commercial rodent pellets and water ad libitum in accordance with the National Institutes of Health Guide for Care and Use of Laboratory Animals [19].

Chemicals. Aged garlic extract (AGE) was purchased as capsules from Wakunaga of America CO., LTD (Mission Viejo, CA, USA). Indomethacin (IND) was purchased from Sigma Chemical Co., St. Louis, MO, USA.

The Experimental Design. The animals were randomly divided into six groups () and subjected orally via stomach tube daily for 30 consecutive days:(1) control subjected water.(2) indomethacin-induced gastric inflammation (IN): the animals were deprived of food but had free access to tap water 24 h before ulcer induction with a single oral dose of indomethacin 30 mg/kg.(3) aged garlic extract (AGE 100): administrated AGE (100 mg/kg).(4) aged garlic extract (AGE 200): administrated AGE (200 mg/kg).(5) indomethacin + aged garlic extract (IN + AGE 100): administrated AGE (100 mg/kg) six hours after IN treatment.(6) indomethacin + aged garlic extract (IN + AGE 200): administrated AGE (100 mg/kg) six hours after IN treatment.

Tissue Sampling. At the end of the experimental duration, the animals were sacrificed (4 h after indomethacin administration in IN-group). Immediately blood collected for serum preparation and the stomachs was separated out the body.

Macroscopic and Histopathological Studies. The isolated stomachs from the control and treated groups were cut along the greater curvature and washed in ice-cold saline and spread out with pins on a cork board and then photographed using a digital camera to assess the inflamed areas of the mucosa in all tested groups. The total gastric mucosal erosive lesions were measured (mm²) with a dissecting microscope under ×20 magnification [20].

The stomachs were then divided into three parts; the first part was fixed in 10% formalin for histopathological examination. Paraffin sections 5 m in thickness were prepared and stained with Haematoxylin and Eosin stain (H&E) to verify histological details [21].

Total Gastric Microflora. Stomach content of the second part rinsed using 10 mL NaCl 0.9%, collected in sterile tube and diluted by buffered sodium chloride peptone solution pH 7. Samples filtered using membrane filtration method, transferred one of the membranes on Casein soybean digest agar plate with sterile forceps, and were incubated 5 days at 30°C–35°C for bacteria. While, the other membrane transferred to sabouraud dextrose agar plate, and incubated for 5 days at 20°C–25°C for fungi. The test strains were Candida albicans (ATCC 2091) and Escherichia coli (ATCC 8739) (ATCC: American Type Culture Collection, Rockville, MD, USA). The total viable aerobic count is the sum of the bacterial average number of colony-forming units (CFU) found on Casein soybean digest agar [22] and that of fungal on Sabouraud dextrose agar [23].

Biochemical Investigations. Serum was used to determine the tumor necrosis factor-α (TNF-α) using Rat TNF-α ELISA (enzyme-Linked Immunosorbent Assay) kit [24] and the third part of stomach tissue was homogenized in a 50 mmol/L phosphate saline buffer (PBS) pH 7.2 under cold condition, using Glass-Teflon homogenizing tube. The homogenate centrifuged at 2500 r/min for 10 min and the supernatant used for the determination of malodialdehyde (MDA) level by the thiobarbituric acid test [25], total glutathione (tGSH) [26], and the enzymes activities of Superoxide Dismutase (SOD) [27], Catalase (CAT) [28], and Myeloperoxidase (MPO) [29].

Statistical Analysis. Data was expressed as means ± SE. Statistical analysis was evaluated by one-way ANOVA. Once a significant test was obtained, LSD comparisons were performed to assess the significance of differences among various treatment groups. Statistical Processor System Support “SPSS” for Windows software, Release 20.0 (SPSS, Chicago, IL), was used.

3. Results

3.1. Effect of AGE on Gastric Inflammation

Indomethacin administration to fasted rats induced gross linear hemorrhagic mucosal lesions. Treatment with AGE showed significant healing effect of the gastric lesions induced by indomethacin in a dose-dependent manner (Figures 1 and 2).

(a)

(b)

(c)

(d)

(e)

(f)

3.2. Effect of AGE Total Gastric Microflora

Indomethacin induced significant increase in the total microbial count (log CFU/g) as compared to that of control (log CFU/g). the total microbial count also increased significantly as compared to control in AGE 100 and AGE200 recording (log CFU/g) and (log CFU/g), respectively, and significantly decreased compared to the IN group result. Treatment with AGE to indomethacin ulcerated group showed significant reduction in the total microbial count in a dose-related effect as compared to IN group value (log CFU/g) recording (log CFU/g) and (log CFU/g) in IN + AGE 100 and IN + AGE 200, respectively (Figure 3).

3.3. Histopathological Effect of AGE on Gastric Inflammation

Indomethacin intake induced severe and extensive macroscopic gastric mucosal damage in the irrigated starved rats, characterized by injury in the epithelial layer of the mucosa and sloughed off gastric mucus (Figure 4(b)) as compared to the normal feature in control group (Figure 4(a)). The disruption in the gastric mucosa partially restored after treatment in IN + AGE 100 group (Figure 4(c)). The gastric mucosal tissues of the IN + AGE 200 treated group (Figure 4(d)) showed almost normal and continuous mucosal layer and formation of the epithelial layer. The efficacy of IN + AGE 200 was better than that of misoprostol as revealed in IN + AGE 100 from Figures 4(d) and 4(c), respectively.

(a)

(b)

(c)

(d)

Figure 4

Light micrographs of control (a) rat stomach demonstrating intact stomach mucosa Haematoxylin-Eosin (H&E ×100). Indomethacin -treated group (b), focusing on superficial mucosal cell, had sloughed off gastric mucus, with infiltration of inflammatory cells (H&E ×100). AGE 100 + IN-treated group (c), showing notable healing effect, showing almost normal mucosa, with exception of mild inflammation (H&E ×100). AGE 200 + IN-treated group (d), showing normal mucosa reflecting the healing impact (H&E ×100).

3.4. Effect of AGE on TNF-α Level

Serum level of proinflammatory cytokine (TNFα) expressed in pg/mL in ulcerated rats upon administration of AGE is presented in Figure 5. Compared with control group the serum level of TNF-α () significantly increased in indomethacin (), AGE 100 (), and IN + AGE 100 () groups. Meanwhile, the serum level of TNF-α significantly decreased in IN + AGE 100 () as compared to the three aforementioned groups.

3.5. Effect of AGE on MDA Level

As represented in Figure 6, administration of indomethacin significantly elevated the gastric mucosal MDA value to nmol/mg as compared to nmol/mg wet tissue for control group. Treatment with AGE to indomethacin-administered group produced significant reduction in gastric mucosal MDA concentration recording nmol/mg IN + AGE 100 and nmol/mg in IN + AGE 200 as compared to indomethacin group.

3.6. Effect of AGE on tGSH Level

As represented in Figure 7, administration of indomethacin significantly decreased the gastric mucosal tGSH value to mol/mg as compared to mol/mg wet tissue for control group. Treatment with AGE to indomethacin-administered group produced significant increase in gastric mucosal tGSH concentration recording mol/mg in IN + AGE 100 group and approaching normal recording mol/mg in IN + AGE 200 as compared to indomethacin group.

3.7. Effect of AGE on SOD and CAT Enzyme Activities

Figures 8 and 9 represented that administration of indomethacin significantly decreased the gastric mucosal SOD and CAT activities to U/mg and mmol/mg, respectively, as compared to U/mg and mmol/mg tissue for control group, respectively. Treatment with AGE to indomethacin-administered group significantly increased the tissue SOD enzyme activity recording U/mg IN + AGE 100 and approaching the normal activity to reach U/mg in IN + AGE 200 as compared to indomethacin group. In the same manner AGE, coadministration to indomethacin-administered group significantly increased the tissue CAT enzyme activity recording mmol/mg IN + AGE 100 and tending to normalize the activity to reach mmol/mg in IN + AGE 200 as compared to indomethacin group.

Figure 8

Effect of aged garlic extract (100 or 200 mg/kg) treatments on stomach tissue superoxide dismutase (SOD) (U/mg) activities from rats treated with or without indomethacin. Data expressed as mean ± SE (). Significance () between groups represented by superscripts as (), significant as compared to control. (a) Significant as compared to IN-group. (b)Significant as compared to AGE 100 group. (c) Significant as compared to AGE 200 group. (d) Significant as compared to IN + AGE 100 group.

3.8. Effect of AGE on MPO Enzyme Activity

The index of neutrophil infiltration in gastric damage by myeloperoxidase enzyme activity was measured in the stomach tissue and represented in Figure 10. In indomethacin treated group MPO activity significantly increased to μmol/mg as compared to μmol/mg tissue for control group. Treatment with AGE to indomethacin-administered group significantly decreased the tissue MPO enzyme activity to reach μmol/mg in IN + AGE 100 group and normalize the activity to reach μmol/mg in IN + AGE 200 as compared to indomethacin group.

Figure 10

Effect of aged garlic extract (100 or 200 mg/kg) treatments on stomach tissue myeloperoxidase (MPO) (μmol/mg) activities from rats treated with or without indomethacin. Data expressed as mean ± SE (). Significance () between groups represented by superscripts as (), significant as compared to control. (a) Significant as compared to IN-group. (b) Significant as compared to AGE 100 group. (c) Significant as compared to AGE 200 group. (d) Significant as compared to IN + AGE 100 group.

4. Discussion

There are many factors implicated in the pathophysiology of the indomethacin ulcerogenic potential establishing it as the first-choice drug to produce an experimental ulcer model because of having a higher ulcerogenic potential than other nonsteroidal anti-inflammatory drugs (NSAIDs) [30]. The ulcerogenic mechanism of indomethacin suggested as accompanied with severe oxidative stress in gastric tissue causing damages to key biomolecules such as lipids, proteins, and DNA leading to increased accumulation of MDA, MPO, and accumulation of reactive products altering enzymatic and nonenzymatic antioxidant parameters leading to enhanced oxidative damage during stomach ulceration [15, 31–34]. In addition, the tumor necrosis factor-a (TNFα) might be the key signal for NSAID-induced gastric inflammation. Where neutrophil accumulation within the gastric microcirculation and the levels of TNFα in the plasma of rats significantly increased following the administration of indomethacin accompanied by gastric injury [12, 35, 36]. In the present study, there are marked damage to the gastric mucosa as evident by macroscopic and histopathological examinations associated with the reduced activities of SOD and CAT and tGSH level, in addition to the elevated TNFα level and MPO activity following indomethacin administration.

As regards to the predicted significant elevation of microflora in our ulcer model could be explained through the previous studies where, in experimental models, bacteria colonization at the stomach ulcer site appears to play an important role in exacerbating mucosal injury and has a clear detrimental effect on its healing [37]. Gram-negative bacteria are likely to be responsible for the observed delay in ulcer healing, whereas Gram-positive bacteria may actually promote ulcer healing. Previous study suggested that bacteria other than Helicobacter pylori have the capacity to significantly influence the ulcer and that ulcers represent an environment conducive to bacterial growth [38]. Other studies evidenced that persistent colonization of the stomach with C. albicans could be achieved in rats by NSAID treatments and that, despite a marked reduction in gastric acid secretion, this infection delays ulcer healing and is accompanied by a fall in mucosal microcirculation in the ulcer area. The delay in ulcer healing induced by Candida combined may be associated with gastric mucosal inflammation that involved overexpression and subsequent release of TNFα [23, 39].

The current study investigated the anti-inflammatory activity of AGE in two doses of AGE (100 and 200 mg/kg) on indomethacin subjected rats. The experimental results showed the advantage of healing potential of the high AGE dose (200 mg/kg) compared to that at dose 100 mg/kg in the gastric mucosal injury induced by indomethacin. The anti-inflammatory activity of AGE was exhibited through its antioxidant activity by resolving the oxidative stress in gastric tissue. AGE is prepared by soaking garlic in ethanol-water mixture for 20 months, which removes irritant compounds from garlic and solubilizes some of the insoluble compounds. The process converts unstable compounds, such as allicin, to stable substances and produces high levels of water-soluble organosulfur compounds that are powerful antioxidants. These include S-allylcysteine (SAC), AGE’s major component, and S-allylmercaptocysteine, unique to AGE. Among other compounds present are low amounts of oil-soluble organosulfur compounds, flavonoids, a phenol, allixin, selenium, and saponins [6, 40–42]. AGE phenolic contents may exert the scavenging activities by donating a hydrogen atom from their phenolic hydroxyl groups [41, 42]. In addition, Na-(1-deoxy-D-fructos-1-yl)-L-arginine (Fru-Arg) was identified as a major antioxidant compound in AGE. The hydrogen peroxide scavenging activity of Fru-Arg was comparable to that of ascorbic acid, suggesting that it could contribute to the pharmacologic effects of AGE through its antioxidant properties [43]. Previously AGE proposed greater safety and efficacy than raw garlic as a therapeutic agent [42]. As regards to the antimicrobial activity of AGE, results in our study are in line with the previous studies, which found that the garlic-derived compound S-allylcysteine (SAC) inhibited the growth of Escherichia coli and enhanced the antibiotic effect of gentamycin [44]. Previous study revealed the dose-dependent antimicrobial efficacy of aqueous garlic extract against 133 multidrug-resistant Gram-positive and Gram-negative bacterial isolates and against 10 Candida spp. The antimicrobial potency of garlic attributed to its ability to inhibit toxin production and expression of enzymes for pathogenesis [45]. The antibacterial and antifungal activities of AGE constituents, allicin, and SAC were previously demonstrated [46–49]. The pattern of resolving oxidative stress in gastric tissue observed through the direct relationship between gastric non-enzymatic tGSH levels and ulcer severity. The tissue, tGSH, and GSH-related enzymes accepted as important protective agents due to their antioxidant properties prevent tissue damage by keeping the ROS at low levels [50, 51]. Aged garlic extract and SAC in both vivo and cell culture-based previous studies recorded to preserve the levels of glutathione peroxidase and glutathione reductase, where glutathione reductase involved in conversion of oxidized glutathione to glutathione [52, 53]. Aged garlic extract treatment significantly prevented induced stress degeneration in morphology and reversed the increased level of MDA and the decreased GSH contents to control values of gastrointestinal mucosa due to its potent free radical scavenging and antioxidant properties [54]. The antioxidant properties of AGE ameliorated oxidative organ injury due to naphthalene toxicity by reversing significantly the elevated MDA levels and MPO activity levels [55]. The study reported that the antioxidant enzymes activities of SOD and CAT have been reversed to normal with 200 mg/kg AGE treatment in IN-administered group these results agree with previous studies reported that garlic extract induces antioxidant effects on rats [56, 57] and suggested that AGE is able to directly scavenge superoxide radicals [58]. Garlic allicin inhibited the TNF-alpha secretion assessing the anti-inflammatory effect of allicin on intestinal epithelial cells [59] and SAC exhibited a dose-dependent inhibition of NF-kappa B activation induced by both TNF-alpha and H₂O₂ in human T lymphocytes (Jurkat cells) [60].

In conclusion, the healing activity of AGE at high dose (200 mg/kg) may be resulted from its ability to scavenge ROS produced by indomethacin administration that initiate lipid peroxidation. The mechanism of gastroprotective effects of the AGE on gastric damage induced by indomethacin may be related to its anti-inflammatory actions and its antioxidant properties, which reduce MDA levels and MPO activity and increase tGSH, SOD, and CAT activities. Therefore, our study suggest that AGE was safe and could be a promising new drug for the prevention of NSAIDs-induced gastric damage.

Conflict of Interests

The authors have declared that no conflict of interests exists.

Acknowledgments

The authors gratefully acknowledge the Deanship of the Scientific Research, King Faisal University, Saudi Arabia, for funding this study (Grant no. 130188). The paper represents original work that is not being considered elsewhere for publication, in whole or in part.

References

C. S. Ramaa, A. R. Shirode, A. S. Mundada, and V. J. Kadam, “Nutraceuticals—an emerging era in the treatment and prevention of cardiovascular diseases,” Current Pharmaceutical Biotechnology, vol. 7, no. 1, pp. 15–23, 2006.
View at: Publisher Site | Google Scholar
P. Karuppiah and S. Rajaram, “Antibacterial effect of Allium sativum cloves and Zingiber officinale rhizomes against multiple-drug resistant clinical pathogens,” Asian Pacific Journal of Tropical Biomedicine, vol. 2, no. 8, pp. 597–601, 2012.
View at: Publisher Site | Google Scholar
V. Lanzotti, E. Barile, V. Antignani, G. Bonanomi, and F. Scala, “Antifungal saponins from bulbs of garlic, Allium sativum L. var. Voghiera,” Phytochemistry, vol. 78, pp. 126–134, 2012.
View at: Publisher Site | Google Scholar
G. Şener, Ö. Sehirli, Y. Ipçi et al., “Aqueous garlic extract alleviates isehaemia-reperfusion-induced oxidative hepatic injury in rats,” Journal of Pharmacy and Pharmacology, vol. 57, no. 1, pp. 145–150, 2005.
View at: Publisher Site | Google Scholar
C. Borek, “Antioxidant health effects of aged garlic extract,” Journal of Nutrition, vol. 131, no. 3, pp. 1010–1015, 2001.
View at: Google Scholar
C. Borek, “Garlic reduces dementia and heart-disease risk,” Journal of Nutrition, vol. 136, no. 3, pp. 810–812, 2006.
View at: Google Scholar
S. Kasuga, N. Uda, E. Kyo, M. Ushijima, N. Morihara, and Y. Itakura, “Pharmacologic activities of aged garlic extract in comparison with other garlic preparations,” Journal of Nutrition, vol. 131, no. 3, pp. 1080–1084, 2001.
View at: Google Scholar
K. Rahman, “Garlic and aging: new insights into an old remedy,” Ageing Research Reviews, vol. 2, no. 1, pp. 39–56, 2003.
View at: Publisher Site | Google Scholar
H. Amagase, “Clarifying the real bioactive constituents of garlic,” Journal of Nutrition, vol. 136, no. 3, pp. 716–725, 2006.
View at: Google Scholar
X. Zhang, K. Tajima, K. Kageyama, and T. Kyoi, “Irsogladine maleate suppresses indomethacin-induced elevation of proinflammatory cytokines and gastric injury in rats,” World Journal of Gastroenterology, vol. 14, no. 30, pp. 4784–4790, 2008.
View at: Publisher Site | Google Scholar
S. K. Vemula, M. B. Chawada, K. S. Thakur, and M. K. Vahalia, “Antiulcer activity of Amlapitta Mishran suspension in rats: a pilot study,” Ancient Science of Life, vol. 32, no. 2, pp. 112–115, 2012.
View at: Google Scholar
A. M. Abbas and H. F. Sakr, “Effect of selenium and grape seed extract on indomethacin-induced gastric ulcers in rats,” Journal of Physiology and Biochemistry, vol. 69, no. 3, pp. 527–537, 2013.
View at: Google Scholar
K. Takeuchi, “Pathogenesis of NSAID-induced gastric damage: importance of cyclooxygenase inhibition and gastric hypermotility,” World Journal of Gastroenterology, vol. 18, no. 18, pp. 2147–21460, 2012.
View at: Google Scholar
A. Burke, E. M. Smyth, and G. A. FitzGerald, “Analgesic-antipyretic and antiin-inflammatory drugs; pharmacotherapy of gout,” in Goodman & Gilman's the Pharmacological Basis of therapeutics, L. Brunton, J. Lazo, and K. Parker, Eds., pp. 671–716, McGrawHill, Columbus, Ohio, USA, 11th edition, 2006.
View at: Google Scholar
J.-H. Kim, B.-W. Kim, H.-J. Kwon, and S.-W. Nam, “Curative effect of selenium against indomethacin-induced gastric ulcers in rats,” Journal of Microbiology and Biotechnology, vol. 21, no. 4, pp. 400–404, 2011.
View at: Publisher Site | Google Scholar
M. Itoh and P. H. Guth, “Role of oxygen-derived free radicals in hemorrhagic shock-induced gastric lesions in the rat,” Gastroenterology, vol. 88, no. 5 I, pp. 1162–1167, 1985.
View at: Google Scholar
R. K. Banerjee, “Nonsteroidal anti-inflammatory drugs inhibit gastric peroxidase activity,” Biochimica et Biophysica Acta, vol. 1034, no. 3, pp. 275–280, 1990.
View at: Publisher Site | Google Scholar
D. Das, D. Bandyopadhyay, M. Bhattacharjee, and R. K. Banerjee, “Hydroxyl radical is the major causative factor in stress-induced gastric ulceration,” Free Radical Biology and Medicine, vol. 23, no. 1, pp. 8–18, 1997.
View at: Publisher Site | Google Scholar
National Institutes of Health Guide for the Care and Use of Laboratory Animals, No. 86-23, NIH Publication, Bethesda, Md, USA, 1985.
S. Bhattacharya, D. Banerjee, A. K. Bauri, S. Chattopadhyay, and S. K. Bandyopadhyay, “Healing property of the Piper betel phenol, allylpyrocatechol against indomethacin-induced stomach ulceration and mechanism of action,” World Journal of Gastroenterology, vol. 13, no. 27, pp. 3705–3713, 2007.
View at: Google Scholar
A. H. Shah, Z. A. Khan, M. Z. A. Baig, S. Qureshi, and A. M. Al-Bekairi, “Gastroprotective effects of pretreatment with Zizyphus sativa fruits against toxic damage in rats,” Fitoterapia, vol. 68, no. 3, pp. 226–234, 1997.
View at: Google Scholar
H. Hosseinzadeh, B. S. Fazly Bazzaz, and M. M. Haghi, “Antibacterial activity of total extracts and essential oil of Nigella sativa L. seeds in mice,” Pharmacologyonline, vol. 2, pp. 429–435, 2007.
View at: Google Scholar
T. Brzozowski, M. Zwolinska-Wcislo, P. C. Konturek et al., “Influence of gastric colonization with Candida albicans on ulcer healing in rats: effect of ranitidine, aspirin and probiotic therapy,” Scandinavian Journal of Gastroenterology, vol. 40, no. 3, pp. 286–296, 2005.
View at: Publisher Site | Google Scholar
B. Bonavida, “Immunomodulatory effect of tumor necrosis factor,” Biotherapy, vol. 3, no. 2, pp. 127–133, 1991.
View at: Google Scholar
H. Ohkawa, N. Ohishi, and K. Yagi, “Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction,” Analytical Biochemistry, vol. 95, no. 2, pp. 351–358, 1979.
View at: Google Scholar
J. Sedlak and R. H. Lindsay, “Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent,” Analytical Biochemistry, vol. 25, pp. 192–205, 1968.
View at: Google Scholar
S. Kwiecień, T. Brzozowski, P. C. Konturek, and S. J. Konturek, “The role of reactive oxygen species in action of nitric oxide-donors on stress-induced gastric mucosal lesions,” Journal of Physiology and Pharmacology, vol. 53, no. 4, pp. 761–773, 2002.
View at: Google Scholar
H. Aebi, “Catalase in vitro,” Methods in Enzymology, vol. 105, pp. 121–126, 1984.
View at: Publisher Site | Google Scholar
J. E. Krawisz, P. Sharon, and W. F. Stenson, “Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models,” Gastroenterology, vol. 87, no. 6, pp. 1344–1350, 1984.
View at: Google Scholar
H. Suleyman, A. Albayrak, M. Bilici, E. Cadirci, and Z. Halici, “Different mechanisms in formation and prevention of indomethacin-induced gastric ulcers,” Inflammation, vol. 33, no. 4, pp. 224–234, 2010.
View at: Publisher Site | Google Scholar
T. Yoshikawa, Y. Naito, A. Kishi et al., “Role of active oxygen, lipid peroxidation, and antioxidants in the pathogenesis of gastric mucosal injury induced by indomethacin in rats,” Gut, vol. 34, no. 6, pp. 732–737, 1993.
View at: Google Scholar
Y. Naito, T. Yoshikawa, N. Yoshida, and M. Kondo, “Role of oxygen radical and lipid peroxidation in indomethacin-induced gastric mucosal injury,” Digestive Diseases and Sciences, vol. 43, no. 9, pp. 30–34, 1998.
View at: Google Scholar
C. Pozzoli, A. Menozzi, D. Grandi et al., “Protective effects of proton pump inhibitors against indomethacin-induced lesions in the rat small intestine,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 374, no. 4, pp. 283–291, 2007.
View at: Publisher Site | Google Scholar
Y. Pérez, A. Oyárzabal, R. Mas, V. Molina, and S. Jiménez, “Protective effect of D-002, a mixture of beeswax alcohols, against indomethacin-induced gastric ulcers and mechanism of action,” Journal of Natural Medicines, vol. 67, no. 1, pp. 182–189, 2013.
View at: Google Scholar
L. Santucci, S. Fiorucci, M. Giansanti, P. M. Brunori, F. M. Di Matteo, and A. Morelli, “Pentoxifylline prevents indomethacin induced acute gastric mucosal damage in rats: role of tumour necrosis factor alpha,” Gut, vol. 35, no. 7, pp. 909–915, 1994.
View at: Google Scholar
S.-Z. Ding, S.-K. Lam, S.-T. Yuen et al., “Prostaglandin, tumor necrosis factor α and neutrophils: causative relationship in indomethacin-induced stomach injuries,” European Journal of Pharmacology, vol. 348, no. 2-3, pp. 257–263, 1998.
View at: Publisher Site | Google Scholar
T. Yamada, E. Deitch, R. D. Specian, M. A. Perry, R. Balfour Sartor, and M. B. Grisham, “Mechanisms of acute and chronic intestinal inflammation induced by indomethacin,” Inflammation, vol. 17, no. 6, pp. 641–662, 1993.
View at: Publisher Site | Google Scholar
S. N. Elliott, A. Buret, W. McKnight, M. J. S. Miller, and J. L. Wallace, “Bacteria rapidly colonize and modulate healing of gastric ulcers in rats,” American Journal of Physiology, vol. 275, no. 3, pp. G425–G432, 1998.
View at: Google Scholar
K. Moriya, N. N. Miura, Y. Adachi, and N. Ohno, “Systemic inflammatory response associated with augmentation and activation of leukocytes in Candida/indomethacin administered mice,” Biological and Pharmaceutical Bulletin, vol. 25, no. 6, pp. 816–822, 2002.
View at: Publisher Site | Google Scholar
J. Imai, N. Ide, S. Nagae, T. Moriguchi, H. Matsuura, and Y. Itakura, “Antioxidant and radical scavenging effects of aged garlic extract and its constituents,” Planta Medica, vol. 60, no. 5, pp. 417–420, 1994.
View at: Publisher Site | Google Scholar
T. Sawa, M. Nakao, T. Akaike, K. Ono, and H. Maeda, “Alkylperoxyl radical-scavenging activity of various flavonoids and other phenolic compounds: implications for the anti-tumor-promoter effect of vegetables,” Journal of Agricultural and Food Chemistry, vol. 47, no. 2, pp. 397–402, 1999.
View at: Publisher Site | Google Scholar
J.-H. Park, Y. K. Park, and E. Park, “Antioxidative and antigenotoxic effects of garlic (Allium sativum L.) prepared by different processing methods,” Plant Foods for Human Nutrition, vol. 64, no. 4, pp. 244–249, 2009.
View at: Publisher Site | Google Scholar
K. Ryu, N. Ide, H. Matsuura, and Y. Itakura, “Nα-(1-deoxy-D-fructos-1-yl)-L-arginine, an antioxidant compound identified in aged garlic extract,” Journal of Nutrition, vol. 131, no. 3, pp. 972–976, 2001.
View at: Google Scholar
P. D. Maldonado, M. E. Chánez-Cárdenas, and J. Pedraza-Chaverrí, “Aged garlic extract, garlic powder extract, S-allylcysteine, diallyl sulfide and diallyl disulfide do not interfere with the antibiotic activity of gentamicin,” Phytotherapy Research, vol. 19, no. 3, pp. 252–254, 2005.
View at: Publisher Site | Google Scholar
B. A. Iwalokun, A. Ogunledun, D. O. Ogbolu, S. B. Bamiro, and J. Jimi-Omojola, “In vitro antimicrobial properties of aqueous garlic extract against multidrug-resistant bacteria and Candida species from Nigeria,” Journal of Medicinal Food, vol. 7, no. 3, pp. 327–333, 2004.
View at: Publisher Site | Google Scholar
S. Ankri and D. Mirelman, “Antimicrobial properties of allicin from garlic,” Microbes and Infection, vol. 1, no. 2, pp. 125–129, 1999.
View at: Publisher Site | Google Scholar
J.-I. Sasaki, T. Kita, K. Ishita, H. Uchisawa, and H. Matsue, “Antibacterial activity of garlic powder against Escherichia coli O-157,” Journal of Nutritional Science and Vitaminology, vol. 45, no. 6, pp. 785–790, 1999.
View at: Google Scholar
H. Matsuura, “Saponins in garlic as modifiers of the risk of cardiovascular disease,” Journal of Nutrition, vol. 131, no. 3, pp. 1000–1005, 2001.
View at: Google Scholar
A. L. Colín-González, R. A. Santana, C. A. Silva-Islas, M. E. Chánez-Cárdenas, A. Santamaría, and P. D. Maldonado, “The antioxidant mechanisms underlying the aged garlic extract- and S-allylcysteine-induced protection,” Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 907162, 12 pages, 2012.
View at: Publisher Site | Google Scholar
H. Sies, “Oxidative stress: oxidants and antioxidants,” Experimental Physiology, vol. 82, no. 2, pp. 291–295, 1997.
View at: Google Scholar
K. B. Ajaikumar, M. Asheef, B. H. Babu, and J. Padikkala, “The inhibition of gastric mucosal injury by Punica granatum L. (pomegranate) methanolic extract,” Journal of Ethnopharmacology, vol. 96, no. 1-2, pp. 171–176, 2005.
View at: Publisher Site | Google Scholar
N. Ide and B. H. S. Lau, “S-Allylcysteine attenuates oxidative stress in endothelial cells,” Drug Development and Industrial Pharmacy, vol. 25, no. 5, pp. 619–624, 1999.
View at: Publisher Site | Google Scholar
P. D. Maldonado, D. Barrera, O. N. Medina-Campos, R. Hernández-Pando, M. E. Ibarra-Rubio, and J. Pedraza-Chaverrí, “Aged garlic extract attenuates gentamicin induced renal damage and oxidative stress in rats,” Life Sciences, vol. 73, no. 20, pp. 2543–2556, 2003.
View at: Publisher Site | Google Scholar
A. Zeybek, F. Ercan, Ş. Çetinel, E. Çikler, B. Saglam, and G. Şener, “Protective effects of aqueous garlic extract in reducing water avoidance stress-induced degeneration of the stomach, ileum, and liver: morphological and biochemical study,” Digestive Diseases and Sciences, vol. 52, no. 11, pp. 2984–2992, 2007.
View at: Publisher Site | Google Scholar
G. Z. Omurtag, F. D. Güranlioǧlu, Ö. Şehirli et al., “Protective effect of aqueous garlic extract against naphthalene-induced oxidative stress in mice,” Journal of Pharmacy and Pharmacology, vol. 57, no. 5, pp. 623–630, 2005.
View at: Publisher Site | Google Scholar
M. A. Abdel-Wahhab and S. E. Aly, “Antioxidants and radical scavenging properties of vegetable extracts in rats fed aflatoxin-contaminated diet,” Journal of Agricultural and Food Chemistry, vol. 51, no. 8, pp. 2409–2414, 2003.
View at: Publisher Site | Google Scholar
H. A. El-Beshbishy, “Aqueous garlic extract attenuates hepatitis and oxidative stress induced by galactosamine/lipoploysaccharide in rats,” Phytotherapy Research, vol. 22, no. 10, pp. 1372–1379, 2008.
View at: Publisher Site | Google Scholar
N. Morihara, M. Hayama, and H. Fujii, “Aged garlic extract scavenges superoxide radicals,” Plant Foods for Human Nutrition, vol. 66, no. 1, pp. 17–21, 2011.
View at: Publisher Site | Google Scholar
A. Lang, M. Lahav, E. Sakhnini et al., “Allicin inhibits spontaneous and TNF-α induced secretion of proinflammatory cytokines and chemokines from intestinal epithelial cells,” Clinical Nutrition, vol. 23, no. 5, pp. 1199–1208, 2004.
View at: Publisher Site | Google Scholar
Z. Geng, Y. Rong, and B. H. S. Lau, “S-allyl cysteine inhibits activation of nuclear factor kappa B in human T cells,” Free Radical Biology and Medicine, vol. 23, no. 2, pp. 345–350, 1997.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2014 Gehan Moustafa Badr and Jawaher Abdulaziz AL-Mulhim. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

3316

Downloads

1432

Citations